Company Overview of Igeneon GmbH
Igeneon GmbH develops and supplies cancer vaccines. It offers antibodies and other components of the patient's immune system to combat cancer. The company was founded in 1999 and is based in Vienna, Austria. As of March 24, 2005, Igeneon GmbH operates as a subsidiary of Aphton Corp.
Brunner Strasse 69
Founded in 1999
43 1 902 50
43 1 902 50 901
Key Executives for Igeneon GmbH
Similar Private Companies By Industry
|AOP Orphan Pharmaceuticals AG||Europe|
|AVIR Green Hills Biotechnology AG||Europe|
|Bartenstein Holding GmbH||Europe|
|BioLife Science Forschungs- und Entwicklungsges. m. b. H.||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Igeneon GmbH, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.